A treatment cycle with ranibizumab costs approximately 800 euros.
Notes on verification
Figure of ~800 euros is corroborated by the ISS source and closely matches AGCM's ~900 euro figure and legal documents citing 902 euro; minor terminology inconsistency between 'treatment cycle' and 'single injection' across sources, and price varied over time (2007-2014).
Sources
- Procedura di infrazione da parte dell'Autorità Antitrust (epicentro.iss.it)
- https://www.agcm.it/media/comunicati-stampa/2014/3/alias-6801 (agcm.it)
- https://www.diritto.it/avastin-vs-lucentis-atto-finale/ (diritto.it)
- https://www.aboutpharma.com/legal-regulatory/caso-avastin-lucentis-francia-e-turchia-cancellano-le-multe-cosa-fara-litalia/ (aboutpharma.com)